- Raised $71M funding round, Jul 2020
- Raised $27.8M funding round, Feb 2019
- Raised $15.8M funding round, Aug 2016
About
Sight Diagnostics uses advanced computer-vision and machine-learning technology in the field of blood diagnostics. The companys initial product, the Parasight platform, is a highly accurate, easy-to-use device for diagnosing malaria. Sight Diagnostics is also applying its technology to the complete blood count (CBC) market, developing a point-of-care CBC platform that will provide a five-point differential blood count for use in doctors offices and emergency medical centers. Beyond its malaria and CBC platforms, the companys computer-vision technology has the potential to unlock advanced diagnostic approaches to numerous additional diseases and provide patients with accurate and inexpensive testing. In December 2019, the company received FDA 510(k) clearance for its OLO analyzer, a device that performs blood tests and provides lab-grade results in minutes. Tests include the complete blood count (CBC) panel, which comprises the most common and useful tests conducted by medical professionals.
Funding history · 5 rounds · $123.8M total
Q&A
- What is Sight Diagnostics' primary business?
- Sight Diagnostics develops advanced blood diagnostics platforms using computer-vision and machine-learning technology. Their products include the Parasight platform for malaria diagnosis and the OLO analyzer for complete blood count (CBC) tests.
- When was Sight Diagnostics founded?
- Sight Diagnostics was founded in September 2010.
- What is the total amount of funding Sight Diagnostics has raised to date?
- Sight Diagnostics has raised a total of $123.8 million USD.
- When did Sight Diagnostics receive FDA clearance for its OLO analyzer?
- In December 2019, Sight Diagnostics received FDA 510(k) clearance for its OLO analyzer, which performs blood tests and provides lab-grade results for complete blood count (CBC) panels.
- Who were the lead investors in Sight Diagnostics' $71 million funding round in July 2020?
- The $71 million funding round in July 2020 included investors Koch Disruptive Technologies and Longliv Ventures.
- How many employees does Sight Diagnostics currently have?
- Sight Diagnostics has 51-200 employees.
- What technologies does Sight Diagnostics utilize in its products?
- Sight Diagnostics utilizes Artificial Intelligence, Computer Vision, and Machine Learning in its diagnostic technologies.
- Who are the co-founders of Sight Diagnostics?
- The co-founders of Sight Diagnostics are Daniel Levner, who serves as Co-founder & Chairman of the Scientific Advisory Board, and Yossi Pollak, who is the Co-founder & CEO.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sightdx.com/en |
|---|---|
| linkedin.com/company/5066984 | |
| facebook.com/sightdx | |
| YouTube | youtube.com/channel/UCHlPq_nv5YWet6nyvNDKRWw |
Identifiers & details
| Founded | 2010-9 |
|---|---|
| Employees (exact) | 69 |
Radar intelligence
Patents
| EPO | 23 |
|---|
Web history (Wayback)
| Domain | sightdx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 14 |
|---|